TRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHL
Condition(s):Non-hodgkin Lymphoma,B CellLast Updated:July 6, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Non-hodgkin Lymphoma,B CellLast Updated:July 6, 2023Recruiting
Condition(s):Solid TumorLast Updated:March 15, 2024Recruiting
Condition(s):Bladder Carcinoma; Breast Cancer; Esophagus Carcinoma; Lung Cancer; Melanoma; Multiple Myeloma; Neuroblastoma; Ovarian Cancer; Synovial Sarcoma; Other Metastatic Solid CancersLast Updated:August 3, 2016Unknown status
Condition(s):Non-hodgkin Lymphoma,B CellLast Updated:March 25, 2024Recruiting
Condition(s):Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-RemittingLast Updated:February 20, 2009Unknown status
Condition(s):Blood CancerLast Updated:May 26, 2022Not yet recruiting
Condition(s):Melanoma; Meningioma; Breast Cancer; Non-Small Cell Lung Cancer; Hepatocellular CancerLast Updated:March 24, 2021Completed
Condition(s):Colon Cancer; CancerLast Updated:January 14, 2022Unknown status
Condition(s):Prostate Specific Antigens; Prostate NeoplasmsLast Updated:October 12, 2022Completed
Condition(s):Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Triple-Negative Breast Carcinoma; Metastatic Urothelial Carcinoma; Stage IV Lung Cancer AJCC v8Last Updated:August 3, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.